Bristol Myers Squibb (BMY) Q2 2024 Results

Bristol Myers Squibb's research and development center at Cambridge Crossing in Cambridge, Massachusetts, on December 27, 2023. Adam Glanzman |…

Pfizer's gene therapy for hemophilia A successfully passes late-stage trials

Kena Betancur | Corbis News | Getty Images Pfizer On Wednesday, the US drugmaker announced that its experimental gene therapy…